Expression-Based GWAS Reveals Role for Immune Cell Receptor in T2D | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – In a study set to appear online this week in the Proceedings of the National Academy of Sciences, researchers from the US and Japan report that they have linked an immune-cell receptor called CD44 to type 2 diabetes using an expression-based genome-wide association study, or eGWAS, strategy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: certain genes repressed during memory formation, analysis of genomes from single neurons, and more.

NASA plans to test whether DNA sequencing studies can be conducted in microgravity.

Congress passes a continuing resolution to keep the US federal government funded through mid-December.

The Human Genome Project was launched 25 years ago, and at Nature, Francis Collins, James Watson, and Eric Green look back at the lessons learned.